Beatrice Burke, MD
Obstetrics/Gynecology · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 4 carriers
- Office
- 1
- Since medical school
- 39 years
- Js Weill Medical College, Cornell University, 1987
Offices
1 location · UCSF Health Medical Foundation · 65 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Burke’s office at (510) 428-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G71260 · Current
Licensed to practise in California · since 1991 · expires 2027-04-30 · Cornell University Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$15,851
Medicare paid this office $15,851 for 96 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 57 | $4,130 | $64 |
| Return visit (30+ min) | 24 | $3,567 | $115 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 63 | $2,979 | $47 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 44 | $2,492 | $57 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 49 | $867 | $18 |
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
96 Original Medicare patients in 2024. Average age 74 · Women 100% · Also on Medicaid 0% · Health risk score 0.62. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 52% · Diabetes 16% · Chronic kidney disease 16% · Depression 13%.
The office billed $61,774, Medicare allowed $20,737 and paid $15,851; for 272 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 96 | 272 | 74 | 0.62 | $61,774 | $15,851 |
| 2023 | 81 | 228 | 73 | 0.53 | $56,083 | $13,384 |
| 2022 | 65 | 131 | 73 | 0.53 | $35,941 | $10,094 |
| 2021 | 69 | 166 | 74 | 0.58 | $31,349 | $11,033 |
| 2020 | 47 | 88 | 74 | 0.63 | $25,391 | $5,359 |
| 2019 | 74 | 158 | 73 | 0.81 | $41,900 | $11,293 |
| 2018 | 74 | 124 | 75 | 0.87 | $23,920 | $8,689 |
| 2017 | 81 | 151 | 75 | 0.93 | $21,595 | $9,211 |
| 2016 | 117 | 190 | 74 | 0.79 | $36,840 | $14,701 |
| 2015 | 66 | 107 | 74 | 0.79 | $14,338 | $8,062 |
| 2014 | 62 | 113 | 73 | 0.94 | $11,164 | $7,210 |
| 2013 | 51 | 100 | 74 | 0.68 | $8,641 | $5,717 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 51 | $4,152 | $70 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 51 | $2,391 | $47 |
| Return visit (30+ min) | 21 | $2,364 | $99 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 40 | $2,186 | $55 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 39 | $690 | $18 |
2022: 4 services
| Return visit (30+ min) | 33 | $4,293 | $100 |
| Short return visit (20+ min) | 27 | $2,377 | $77 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,253 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 20 | $1,067 | $53 |
2021: 4 services
| Short return visit (20+ min) | 50 | $4,052 | $78 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 53 | $2,495 | $47 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 41 | $2,212 | $54 |
| Return visit (30+ min) | 12 | $1,381 | $106 |
2020: 4 services
| Return visit (30+ min) | 24 | $1,873 | $75 |
| Short return visit (20+ min) | 24 | $1,304 | $48 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $799 | $47 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $797 | $53 |
2019: 4 services
| Return visit (30+ min) | 28 | $2,565 | $88 |
| Short return visit (20+ min) | 29 | $2,088 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 43 | $1,974 | $46 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 37 | $1,962 | $53 |
2018: 4 services
| Return visit (30+ min) | 45 | $4,254 | $85 |
| Short return visit (20+ min) | 11 | $1,550 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 23 | $1,002 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 17 | $897 | $53 |
2017: 4 services
| Short return visit (20+ min) | 22 | $2,912 | $59 |
| Return visit (30+ min) | 37 | $2,502 | $68 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,187 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,151 | $43 |
2016: 5 services
| Return visit (30+ min) | 41 | $3,879 | $95 |
| Short return visit (20+ min) | 31 | $3,198 | $61 |
| New patient visit (45+ min) | 14 | $1,794 | $128 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 33 | $1,776 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 38 | $1,668 | $44 |
2015: 4 services
| Short return visit (20+ min) | 17 | $1,349 | $61 |
| Return visit (30+ min) | 13 | $1,227 | $94 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 25 | $1,059 | $42 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 16 | $830 | $52 |
2014: 3 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 29 | $1,246 | $43 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,205 | $52 |
| Short return visit (20+ min) | 15 | $1,059 | $62 |
2013: 4 services
| Return visit (30+ min) | 14 | $1,135 | $81 |
| Short return visit (20+ min) | 17 | $1,105 | $58 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $867 | $43 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $810 | $54 |
Drugs they prescribed that Part D paid
$11,073
Pharmacies billed $11,073 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
136 generic and 12 brand-name prescriptions · $11,073 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 77 | $5,673 | $74 |
| Clotrimazole-Betamethasone | 12 | $270 | $22 |
Year by year
| 2024 | 148 | 64 | None | 8% | $11,073 |
| 2023 | 124 | 49 | None | 11% | $10,742 |
| 2022 | 129 | 46 | None | 13% | $12,624 |
| 2021 | 104 | 37 | 0% (0) | 17% | $11,886 |
| 2020 | 88 | 36 | 0% (0) | 14% | $14,400 |
| 2019 | 85 | 39 | 0% (0) | 18% | $9,192 |
| 2018 | 70 | 34 | 0% (0) | 24% | $11,022 |
| 2017 | 92 | 48 | None | 16% | $14,335 |
| 2016 | 55 | 36 | None | None | $5,544 |
| 2015 | 29 | 24 | None | None | $3,200 |
| 2014 | 34 | 23 | 0% (0) | 41% | $2,945 |
| 2013 | 56 | 28 | 0% (0) | 20% | $4,637 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Estradiol | 59 | $5,571 | $94 |
2022: 2 drugs
| Estradiol | 58 | $5,408 | $93 |
| Clotrimazole-Betamethasone | 13 | $309 | $24 |
2021: 1 drug
| Estradiol | 47 | $5,219 | $111 |
2020: 1 drug
| Estradiol | 40 | $8,218 | $205 |
2019: 1 drug
| Estradiol | 26 | $4,946 | $190 |
2018: 1 drug
| Estradiol | 16 | $3,821 | $239 |
2017: 1 drug
| Estrace | 24 | $6,831 | $285 |
2016: 1 drug
| Estrace | 12 | $3,148 | $262 |
2013: 1 drug
| Estrace | 11 | $1,551 | $141 |
Money from drug and device companies
$262 in 2025
| 2025 | 6 | 11 | None | $262 |
| 2024 | 3 | 11 | None | $202 |
| 2023 | 6 | 11 | None | $202 |
| 2022 | 2 | 4 | None | $92 |
| 2021 | 4 | 17 | None | $311 |
| 2020 | 4 | 5 | None | $96 |
| 2019 | 11 | 17 | None | $389 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $86 | 3 payments
|
| Biogen | Zurzuvae | $69 | 3 payments
|
| Mayne Pharma Commercial | None | $46 | 2 payments
|
| Minerva Surgical | None | $21 | 1 payment
|
| Hologic Sales and Service | Omni Hysteroscope | $20 | 1 payment
|
| CooperSurgical | Paragard T 380a | $19 | 1 payment
|
See all 11 published payments
| Biogen | Meals · 2025-12-17 | Zurzuvae | $17 |
| Mayne Pharma Commercial | Meals · 2025-10-22 | None | $22 |
| Biogen | Meals · 2025-10-15 | Zurzuvae | $27 |
| Mayne Pharma Commercial | Meals · 2025-08-20 | None | $24 |
| Astellas Pharma US | Meals · 2025-08-06 | Veozah | $27 |
| Minerva Surgical | Meals · 2025-06-18 | None | $21 |
| Biogen | Meals · 2025-05-07 | Zurzuvae | $25 |
| Astellas Pharma US | Meals · 2025-03-05 | Veozah | $28 |
| Astellas Pharma US | Meals · 2025-02-05 | Veozah | $31 |
| CooperSurgical | Meals · 2025-01-29 | Paragard T 380a | $19 |
| Hologic Sales and Service | Meals · 2025-01-09 | Omni Hysteroscope | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $202
| Mayne Pharma Commercial | None | $146 | 9 payments
|
| Ethicon US | Ethicon | $35 | 1 payment
|
| Hologic Sales and Service | Acessa Provu System | $22 | 1 payment
|
2023: $202
| Mayne Pharma Commercial | None | $65 | 5 payments
|
| Exact Sciences | Cologuard Collection Kit | $43 | 2 payments
|
| AbbVie | Orilissa | $26 | 1 payment
|
| Hologic Sales and Service | Aptima | $25 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $22 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
2022: $92
| Abbvie | Liletta | $66 | 3 payments
|
| Pfizer | Myfembree | $26 | 1 payment
|
2021: $311
| AbbVie | Lo Loestrin Fe | $204 | 12 payments
|
| TherapeuticsMD | Annovera | $42 | 2 payments
|
| Daiichi Sankyo | Injectafer | $39 | 2 payments
|
| Pfizer | Myfembree | $26 | 1 payment
|
2020: $96
| Merck Sharp & Dohme | Nexplanon | $39 | 2 payments
|
| Pfizer | Premarin | $22 | 1 payment
|
| AbbVie | Orilissa | $20 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $14 | 1 payment
|
2019: $389
| Merck Sharp & Dohme | Gardasil | $135 | 3 payments
|
| AbbVie | Orilissa | $65 | 3 payments
|
| Pfizer | Premarin | $37 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $34 | 2 payments
|
| CooperSurgical | Paragard | $28 | 1 payment
|
| Daiichi Sankyo | Injectafer | $20 | 1 payment
|
| TherapeuticsMD | Imvexxy | $18 | 1 payment
|
| Vertical Pharmaceuticals | Divigel | $15 | 1 payment
|
| Roche Diagnostics | Rs Harmony Test Related Products | $14 | 1 payment
|
| Avion Pharmaceuticals | Prenate Mini | $13 | 1 payment
|
| Allergan | Lo Loestrin Fe | $12 | 1 payment
|
Professional record
- NPI
- 1033298625
- Licence
- CA G71260California G71260: Current · expires 2027-04-30
- Trained
- Js Weill Medical College, Cornell University, 1987 · 39 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2020 Adeline Dr, Burlingame, CA, 94010
- NPI first listed
- 2006-11-03
- NPI last updated
- 2014-03-09
This is when the NPI record was last certified, not a medical board exam.